> it is hard to control the amount of money the three receive Since it's very hard to know how much that should be, we just inject some cash into the bottom o

> it is hard to control the amount of money the three receive Since it's very hard to know how much that should be, we just inject some cash into the bottom of the market, and let the market distribute the cash. The debate about giving cash vs. medicine is that cash moves around the target community and stimulates lots of things, rather than going direct to a multinational pharma corp's Swiss bank. The risk is that too much of the cash is absorbed by bad actors. As usual, it's a complex trade off and maybe a bit of both would give best results.